Tidewater Eye Centers now offers more options for cataract suffers. Thanks to Food and Drug Administration (FDA) approval, Tidewater Eye Centers now offers the first and only trifocal lens for patients undergoing cataract surgery: the Alcon AcrySof® IQ PanOptix® Trifocal Intraocular Lens.
The PanOptix lens has been clinically shown to offer patients a combination of near, intermediate and distance vision while reducing the need for glasses after surgery.
“I have been inserting bifocal lenses during cataract surgery for over 15 years and there was always a tradeoff. Many patients still needed glasses for reading up close. I am very excited to now offer our patients a trifocal option which is the next step to spectacle independence,” says Dr. Tom Edmonds.
Dr. Edmonds was one of the first surgeons in the U.S. to offer this lens since it was approved in the U.S. on August 30, 2019. He has been very pleased with the results so far. “The PanOptix lens has allowed my patients to see well at all distances, getting back to the vision they had when they were in their early 40’s. Patients rave about the clarity of their vision and their friends are envious that they no longer need to wear the old glasses.”
Over 99% of patients implanted with this lens in the clinical trials were happy with the results and would have it implanted again. To learn more about this exciting technology, schedule a cataract consultation with Tidewater Eye Centers at any of our three locations.